FlowCardia

Related Content

Technology
FlowCardia Expands Options for Patients With Chronic Total Occlusions

October 22, 2009 – FlowCardia Inc. yesterday began its U.S. launch of the over the wire (OTW) delivery platform for the ...

Home October 22, 2009
arrow
News
FlowMate Injector Launched to Optimize CROSSER CTO Recanalization Catheter

October 7, 2009 – FlowCardia Inc. this week launched the FlowMate Injector, which dramatically simplifies central lumen ...

Home October 07, 2009
arrow
Technology
FlowCardia Peripheral CROSSER Catheter Offers Endovascular Option to Amputation, Bypass Surgery

FlowCardia Inc., a medical device company developing a portfolio of endovascular devices for the treatment of coronary ...

Home October 19, 2008
arrow
News
FlowCardia Introduces Endovascular Option to Amputation, Bypass Surgery

FlowCardia's three peripheral CROSSER Catheters — CROSSER 14P, CROSSER 14S and CROSSER 18 CTO Recanalization — are ...

Home December 11, 2007
arrow
News
FlowCardia Finalizes Enrollment in Catheter Study in CTOs

September 12, 2007 - FlowCardia Inc., a medical device company developing a portfolio of endovascular devices for the ...

Home September 11, 2007
arrow
News
Newly Cleared Catheter Moves Wires Over CTOs

Jan. 23, 2007 — The FDA has granted 510(k) clearance for FlowCardia’s CROSSER 14 CTO Recannalization System, an ...

Home January 22, 2007
arrow
News
First Patient Enrolled in Peripheral Occlusions Study

The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...

Home November 07, 2006
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now